News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,166 Results
Type
Article (14251)
Company Profile (281)
Press Release (253634)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79551)
Career Advice (152)
Deals (13233)
Drug Delivery (35)
Drug Development (50463)
Employer Resources (31)
FDA (5727)
Job Trends (5133)
News (144462)
Policy (10035)
Tag
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21679)
ALS (64)
Alzheimer's disease (848)
Antibody-drug conjugate (ADC) (100)
Approvals (5755)
Artificial intelligence (124)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (232)
Bladder cancer (58)
Brain cancer (20)
Breast cancer (155)
Cancer (1479)
Cardiovascular disease (116)
Career advice (133)
Career pathing (2)
CAR-T (117)
Cell therapy (331)
Cervical cancer (8)
Clinical research (41087)
Collaboration (542)
Compensation (258)
Complete response letters (13)
COVID-19 (1034)
CRISPR (42)
C-suite (164)
Cystic fibrosis (76)
Data (1523)
Denatured (11)
Depression (30)
Diabetes (139)
Diagnostics (1301)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (29837)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48613)
Executive appointments (464)
FDA (6425)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (498)
Gene editing (97)
Generative AI (10)
Gene therapy (254)
GLP-1 (366)
Government (1081)
Grass and pollen (2)
Guidances (22)
Healthcare (6594)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (92)
Indications (20)
Infectious disease (1099)
Inflammatory bowel disease (114)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (17)
IPO (7275)
IRA (11)
Job creations (861)
Job search strategy (127)
Kidney cancer (7)
Labor market (5)
Layoffs (209)
Leadership (3)
Legal (1386)
Liver cancer (33)
Lung cancer (205)
Lymphoma (101)
Machine learning (3)
Management (7)
Manufacturing (140)
MASH (53)
Medical device (2603)
Medtech (2604)
Mergers & acquisitions (6289)
Metabolic disorders (390)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1257)
NextGen: Class of 2025 (2019)
Non-profit (852)
Northern California (1702)
Now hiring (21)
Obesity (194)
Opinion (102)
Ovarian cancer (63)
Pain (43)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (8)
Patents (130)
Patient recruitment (78)
Peanut (35)
People (25653)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14514)
Phase II (19111)
Phase III (12081)
Pipeline (808)
Policy (45)
Postmarket research (852)
Preclinical (6142)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (292)
Real estate (1419)
Recruiting (12)
Regulatory (8643)
Reports (15)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (60)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1487)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1979)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (9)
The Weekly (36)
United States (13267)
Vaccines (213)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (91)
Last 7 days (509)
Last 30 days (1516)
Last 365 days (19570)
2025 (6282)
2024 (20552)
2023 (22417)
2022 (26824)
2021 (27808)
2020 (23360)
2019 (16230)
2018 (11742)
2017 (13749)
2016 (11843)
2015 (14353)
2014 (10397)
2013 (7488)
2012 (7539)
2011 (7619)
2010 (7429)
Location
Africa (148)
Alabama (42)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17315)
Australia (2935)
California (3862)
Canada (1141)
China (360)
Colorado (149)
Connecticut (151)
Delaware (102)
Europe (37295)
Florida (465)
Georgia (116)
Idaho (16)
Illinois (232)
India (10)
Indiana (91)
Iowa (2)
Japan (75)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (473)
Massachusetts (3082)
Michigan (70)
Minnesota (145)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (967)
New Mexico (12)
New York (1045)
North Carolina (553)
North Dakota (5)
Northern California (1702)
Ohio (112)
Oklahoma (9)
Oregon (21)
Pennsylvania (741)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (4)
Southern California (1487)
Tennessee (25)
Texas (448)
Utah (53)
Virginia (79)
Washington D.C. (30)
Washington State (351)
Wisconsin (15)
268,166 Results for "capricor therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day
April 2, 2025
·
4 min read
Press Releases
Capricor Therapeutics to Participate in Upcoming Investor Conferences
February 10, 2025
·
4 min read
Press Releases
Capricor Therapeutics to Present at Leerink’s Global Healthcare Conference 2025
March 7, 2025
·
4 min read
Press Releases
Capricor Therapeutics Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel for the Treatment of Duchenne Muscular Dystrophy
March 17, 2025
·
7 min read
Press Releases
Capricor Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
March 20, 2025
·
14 min read
Press Releases
Capricor Therapeutics to Present Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update on March 19
March 11, 2025
·
4 min read
Press Releases
Capricor Therapeutics Announces FDA Acceptance and Priority Review of its Biologics License Application for Deramiocel to Treat Duchenne Muscular Dystrophy
March 5, 2025
·
7 min read
Press Releases
Capricor Therapeutics to Present at Upcoming Investor Conferences
December 3, 2024
·
4 min read
Biotech Beach
Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy
Capricor Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has scheduled a Pre-BLA (Biologics License Application) meeting with the Company in the third quarter of 2024 for deramiocel (CAP-1002), for the treatment of Duchenne Muscular Dystrophy (DMD).
June 25, 2024
·
5 min read
Capricor Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
Capricor Therapeutics announced that the Company is set to join the Russell 2000® Index and the broad-market Russell 3000® Index, effective at the open of U.S. equity markets, July 1, 2024.
July 1, 2024
·
5 min read
1 of 26,817
Next
